TippingPoint Biosciences

TippingPoint Biosciences is developing therapeutics that target genome packaging states in diseases like cancer.

Health and bio

TippingPoint Biosciences raised $4.5M in a Seed round announced March 31, 2026, according to Pulse 2.0.

Founders and team

• LH
  Laura Hsieh Founder

  source: crunchbase.com

Raise history

1. March 31, 2026
   Seed · $4.5M
   Source: Pulse 2.0

Related bio health companies

• SSharp$328K · Oct 1, 2026
• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• VVytalYou$830K · Sep 30, 2026
• LLindera USSep 29, 2026
• OOrtet$500M · Sep 29, 2026
• AAptadir Therapeutics$45M · Sep 29, 2026
• GGoerSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/tippingpoint-biosciences.